Effectiveness of Pharmacotherapy Follow-Up for the Control of Hypertensive Patients in Community Pharmacies: EMDADER-HTA Study

ABSTRACT: The present study was designed to evaluate the effect of pharmacotherapy follow-up (PFU) on blood pressure (BP) readings, total cholesterol (TC) levels and cardiovascular risk (CVR) in patients with hypertension and/or hypercholesterolemia, at community pharmacies in Spain. The study was carried out in 18 community pharmacies in Spain with 6 months of PFU. Measurements were taken at: start, 6, 12, and 24 weeks. Hypertensive patients aged 35-74 attended with a prescription for at least one drug indicated primarily for the treatment of hypertension were included. A total of 117 patients completed the study. There were statistically significant increases in the achievement of hypertension targets (23.9%, p < 0.001). There were decreases in the average Wilson-Grundy CVR (-1.5%), CVR SCORE (-0.5%), systolic and diastolic BP (-7.6 mm Hg) (-3.3 mm Hg) and TC (-14.6 mg/dL). PFU carried out by community pharmacists in hypertensive patients attending community pharmacies in Spain improves BP, TC and can achieve BP, TC and CVR reduction.

• Autores: Amariles Muñoz, Pedro; Rodríguez Chamorro, Alfonso; García Jiménez, Emilio; Rodríguez Chamorro, Miguel Ángel; Martínez, Fernando; González García, Lorena; Pérez Merino, Eva María; Faus Dader, María José
• Tipo de recurso: Article of investigation
• Fecha de publicación: 2013
• Institución: Universidad de Antioquia
• Repositorio: Repositorio UdeA
• Idioma: eng
• OAI Identifier: oai:bibliotecadigital.udea.edu.co:10495/36285
• Acceso en línea: https://hdl.handle.net/10495/36285; http://www.latamjpharm.org/
• Palabra clave: Factores de Riesgo de Enfermedad Cardiaca; Heart Disease Risk Factors; Farmacias; Pharmacies; Hipertensión; Hypertension; Informes de Casos; Case Reports
• Rights: openAccess
• License: https://creativecommons.org/licenses/by-nc-nd/4.0/